Evidence map›Paper›PMID 38902255›Full record

ArticleNature communications2024

Multiple roles for hypoxia inducible factor 1-alpha in airway epithelial cells during mucormycosis.

Povilas Kavaliauskas, Yiyou Gu, Naushaba Hasin, Karen T Graf, Abdullah Alqarihi, Amol C Shetty, Carrie McCracken, Thomas J Walsh, Ashraf S Ibrahim, Vincent M Bruno

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Povilas Kavaliauskas *Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Yiyou Gu *Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.
Naushaba Hasin *Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Karen T GrafInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Abdullah AlqarihiDivision of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.ORCID http://orcid.org/0000-0003-4408-6398
Amol C ShettyInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.ORCID http://orcid.org/0000-0001-8790-7649
Carrie McCrackenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Thomas J WalshDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Ashraf S IbrahimDivision of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.ORCID http://orcid.org/0000-0003-3787-8530
Vincent M BrunoDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. vbruno@som.umaryland.edu.ORCID http://orcid.org/0000-0003-1683-2015

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CARNEIRO DA SILVA, JOANA · 2014 to 2023
$36.5M
Novel Toxins and Receptors in Mucormycosis Pathogenesis and TreatmentR01AI063503 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2006 to 2025
$7.3M
Therapeutic targeting of growth factor receptors to treat MucormycosisR01AI141360 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BRUNO, VINCENT MICHAEL · 2019 to 2023
$2.5M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI063503Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI110820Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI141360NIAID NIH HHS R01 AI063503NIAID NIH HHS R01 AI141360NIAID NIH HHS U19 AI110820
6 · The paper itself

Abstract

During pulmonary mucormycosis, inhaled sporangiospores adhere to, germinate, and invade airway epithelial cells to establish infection. We provide evidence that HIF1α plays dual roles in airway epithelial cells during Mucorales infection. We observed an increase in HIF1α protein accumulation and increased expression of many known HIF1α-responsive genes during in vitro infection, indicating that HIF1α signaling is activated by Mucorales infection. Inhibition of HIF1α signaling led to a substantial decrease in the ability of R. delemar to invade cultured airway epithelial cells. Transcriptome analysis revealed that R. delemar infection induces the expression of many pro-inflammatory genes whose expression was significantly reduced by HIF1α inhibition. Importantly, pharmacological inhibition of HIF1α increased survival in a mouse model of pulmonary mucormycosis without reducing fungal burden. These results suggest that HIF1α plays two opposing roles during mucormycosis: one that facilitates the ability of Mucorales to invade the host cells and one that facilitates the ability of the host to mount an innate immune response.

Indexed as

Epithelial CellsHypoxia-Inducible Factor 1, alpha SubunitMucoralesMucormycosisAnimalsDisease Models, AnimalFemaleGene Expression ProfilingHumansLungMiceMice, Inbred C57BLSignal TransductionHIF1A protein, humanHif1a protein, mouseHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

PMID38902255
PMCPMC11190229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.